Hyperion Therapeutics Inc (NASDAQ:HPTX)

30.00
BATS BZX Real-Time Price
As of 10:59am ET
 +2.27 / +8.19%
Today’s Change
20.23
Today|||52-Week Range
32.98
+25.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$568.8M

Company Description

Hyperion Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat disorders in orphan diseases and hepatology. Its product, Ravicti is designed to lower ammonia in blood and for the treatment of urea cycle disorders and hepatic encephalopathy. The company was founded by Mark Blumling and Chris E. Rivera on November 1, 2006 and is headquartered in Brisbane, CA.

Contact Information

Hyperion Therapeutics, Inc.
--
-- California --
P:
Investor Relations:

Employees

Shareholders

Individual stakeholders50.55%
Other institutional31.15%
Mutual fund holders27.80%

Top Executives

There are no executives to display.

To view my watchlist

Not a member yet?

Sign up now for a free account